UNASSIGNED: To evaluate the effect of LTPRA of SPG in treating chronic and episodic CH.
UNASSIGNED: The patients with CH, who achieved temporary pain relief following SPG block, treated using LTPRA between January 2015 and October 2017 were reviewed. Seventy-six patients were included: 50 patients suffered from episodic CH and the remaining 26 patients from chronic CH. The primary outcomes were clinical improvement rate, defined as the percentage of partial and complete pain relief results at 1 day, 12 months, and 24 months of follow-up after the operation.
UNASSIGNED: Clinical improvement rates were 92.3%, 92.3% and 73.1% in chronic CH and 73.1%, 84% and 68% in episodic CH at each follow-up time point, respectively. 3 chronic CH patients and 7 episodic CH patients showed no pain relief after the operation. Drooping eyelids were found in 2 cases, one recovered at the 3-month follow-up but another one did not in the 24-month follow-up. No serious complications occurred intraoperatively or postoperatively.
UNASSIGNED: LTPRA can be considered an effective and alternative surgical modality in treating patients with chronic and episodic CH, based on SPG block.
■评估SPG的LTPRA治疗慢性和发作性CH的效果。
■患有CH的患者,在SPG阻滞后实现了暂时的疼痛缓解,对2015年1月至2017年10月期间使用LTPRA治疗的患者进行了回顾.包括76例患者:50例患有发作性CH,其余26例患有慢性CH。主要结果是临床改善率,定义为1天部分和完全疼痛缓解结果的百分比,12个月,术后24个月随访。
■临床改善率为92.3%,慢性CH分别为92.3%和73.1%和73.1%,每个随访时间点的偶发性CH分别为84%和68%,分别。3例慢性CH患者和7例发作性CH患者术后疼痛无缓解。2例眼睑下垂,其中1人在3个月随访时痊愈,但另1人在24个月随访中未痊愈.术中、术后无严重并发症发生。
■LTPRA可以被认为是治疗慢性和发作性CH患者的有效和替代手术方式,基于SPG块。